Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study
We examined the relationships of whole blood viscosity and its major determinants to incident cardiovascular events (ischaemic heart disease and stroke) in a prospective study of a random population sample of 1592 men and women aged 55–74 years (the Edinburgh Artery Study). 272 fatal and non‐fatal c...
Saved in:
Published in | British journal of haematology Vol. 96; no. 1; pp. 168 - 173 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Science Ltd
01.01.1997
Blackwell |
Subjects | |
Online Access | Get full text |
ISSN | 0007-1048 1365-2141 |
DOI | 10.1046/j.1365-2141.1997.8532481.x |
Cover
Abstract | We examined the relationships of whole blood viscosity and its major determinants to incident cardiovascular events (ischaemic heart disease and stroke) in a prospective study of a random population sample of 1592 men and women aged 55–74 years (the Edinburgh Artery Study). 272 fatal and non‐fatal cardiovascular events occurred during 5 years of follow‐up (cumulative incidence 17.1%). Age and sex adjusted mean levels of blood viscosity (3.70 v 3.55 mPa.s), haematocrit (46.2 v 45.7%), haematocrit‐corrected blood viscosity (3.57 v 3.48 mPa.s), plasma viscosity (1.35 v 1.33 mPa.s) and fibrinogen (2.88 v 2.67 g/l) were significantly higher in subjects who experienced events than in subjects who did not. The relationships of these rheological variables to cardiovascular events were at least as strong as those of conventional risk factors (smoking habit, diastolic blood pressure, and low‐density lipoprotein cholesterol). After adjustment for these conventional risk factors, the associations of blood viscosity and haematocrit remained significant for stroke, but not for total events; whereas the associations of plasma viscosity and fibrinogen remained significant for total events and for stroke.
These findings suggest that increased blood viscosity may be one plausible biological mechanism through which increases in haematocrit and fibrinogen may promote ischaemic heart disease and stroke. Randomized controlled trials of viscosity reduction in the prevention of cardiovascular events (e.g. by lowering high levels of haematocrit or plasma fibrinogen) are suggested. |
---|---|
AbstractList | We examined the relationships of whole blood viscosity and its major determinants to incident cardiovascular events (ischaemic heart disease and stroke) in a prospective study of a random population sample of 1592 men and women aged 55–74 years (the Edinburgh Artery Study). 272 fatal and non‐fatal cardiovascular events occurred during 5 years of follow‐up (cumulative incidence 17.1%). Age and sex adjusted mean levels of blood viscosity (3.70
v
3.55 mPa.s), haematocrit (46.2
v
45.7%), haematocrit‐corrected blood viscosity (3.57
v
3.48 mPa.s), plasma viscosity (1.35
v
1.33 mPa.s) and fibrinogen (2.88
v
2.67 g/l) were significantly higher in subjects who experienced events than in subjects who did not. The relationships of these rheological variables to cardiovascular events were at least as strong as those of conventional risk factors (smoking habit, diastolic blood pressure, and low‐density lipoprotein cholesterol). After adjustment for these conventional risk factors, the associations of blood viscosity and haematocrit remained significant for stroke, but not for total events; whereas the associations of plasma viscosity and fibrinogen remained significant for total events and for stroke.
These findings suggest that increased blood viscosity may be one plausible biological mechanism through which increases in haematocrit and fibrinogen may promote ischaemic heart disease and stroke. Randomized controlled trials of viscosity reduction in the prevention of cardiovascular events (e.g. by lowering high levels of haematocrit or plasma fibrinogen) are suggested. We examined the relationships of whole blood viscosity and its major determinants to incident cardiovascular events (ischaemic heart disease and stroke) in a prospective study of a random population sample of 1592 men and women aged 55–74 years (the Edinburgh Artery Study). 272 fatal and non‐fatal cardiovascular events occurred during 5 years of follow‐up (cumulative incidence 17.1%). Age and sex adjusted mean levels of blood viscosity (3.70 v 3.55 mPa.s), haematocrit (46.2 v 45.7%), haematocrit‐corrected blood viscosity (3.57 v 3.48 mPa.s), plasma viscosity (1.35 v 1.33 mPa.s) and fibrinogen (2.88 v 2.67 g/l) were significantly higher in subjects who experienced events than in subjects who did not. The relationships of these rheological variables to cardiovascular events were at least as strong as those of conventional risk factors (smoking habit, diastolic blood pressure, and low‐density lipoprotein cholesterol). After adjustment for these conventional risk factors, the associations of blood viscosity and haematocrit remained significant for stroke, but not for total events; whereas the associations of plasma viscosity and fibrinogen remained significant for total events and for stroke. These findings suggest that increased blood viscosity may be one plausible biological mechanism through which increases in haematocrit and fibrinogen may promote ischaemic heart disease and stroke. Randomized controlled trials of viscosity reduction in the prevention of cardiovascular events (e.g. by lowering high levels of haematocrit or plasma fibrinogen) are suggested. We examined the relationships of whole blood viscosity and its major determinants to incident cardiovascular events (ischaemic heart disease and stroke) in a prospective study of a random population sample of 1592 men and women aged 55-74 years (the Edinburgh Artery Study). 272 fatal and non-fatal cardiovascular events occurred during 5 years of follow-up (cumulative incidence 17.1%). Age and sex adjusted mean levels of blood viscosity (3.70 v 3.55 mPa.s), haematocrit (46.2 v 45.7%), haematocrit-corrected blood viscosity (3.57 v 3.48 mPa.s), plasma viscosity (1.35 v 1.33 mPa.s) and fibrinogen (2.88 v 2.67 g/l) were significantly higher in subjects who experienced events than in subjects who did not. The relationships of these rheological variables to cardiovascular events were at least as strong as those of conventional risk factors (smoking habit, diastolic blood pressure, and low-density lipoprotein cholesterol). After adjustment for these conventional risk factors, the associations of blood viscosity and haematocrit remained significant for stroke, but not for total events; whereas the associations of plasma viscosity and fibrinogen remained significant for total events and for stroke. These findings suggest that increased blood viscosity may be one plausible biological mechanism through which increases in haematocrit and fibrinogen may promote ischaemic heart disease and stroke. Randomized controlled trials of viscosity reduction in the prevention of cardiovascular events (e.g. by lowering high levels of haematocrit or plasma fibrinogen) are suggested.We examined the relationships of whole blood viscosity and its major determinants to incident cardiovascular events (ischaemic heart disease and stroke) in a prospective study of a random population sample of 1592 men and women aged 55-74 years (the Edinburgh Artery Study). 272 fatal and non-fatal cardiovascular events occurred during 5 years of follow-up (cumulative incidence 17.1%). Age and sex adjusted mean levels of blood viscosity (3.70 v 3.55 mPa.s), haematocrit (46.2 v 45.7%), haematocrit-corrected blood viscosity (3.57 v 3.48 mPa.s), plasma viscosity (1.35 v 1.33 mPa.s) and fibrinogen (2.88 v 2.67 g/l) were significantly higher in subjects who experienced events than in subjects who did not. The relationships of these rheological variables to cardiovascular events were at least as strong as those of conventional risk factors (smoking habit, diastolic blood pressure, and low-density lipoprotein cholesterol). After adjustment for these conventional risk factors, the associations of blood viscosity and haematocrit remained significant for stroke, but not for total events; whereas the associations of plasma viscosity and fibrinogen remained significant for total events and for stroke. These findings suggest that increased blood viscosity may be one plausible biological mechanism through which increases in haematocrit and fibrinogen may promote ischaemic heart disease and stroke. Randomized controlled trials of viscosity reduction in the prevention of cardiovascular events (e.g. by lowering high levels of haematocrit or plasma fibrinogen) are suggested. We examined the relationships of whole blood viscosity and its major determinants to incident cardiovascular events (ischaemic heart disease and stroke) in a prospective study of a random population sample of 1592 men and women aged 55-74 years (the Edinburgh Artery Study). 272 fatal and non-fatal cardiovascular events occurred during 5 years of follow-up (cumulative incidence 17.1%). Age and sex adjusted mean levels of blood viscosity (3.70 v 3.55 mPa.s), haematocrit (46.2 v 45.7%), haematocrit-corrected blood viscosity (3.57 v 3.48 mPa.s), plasma viscosity (1.35 v 1.33 mPa.s) and fibrinogen (2.88 v 2.67 g/l) were significantly higher in subjects who experienced events than in subjects who did not. The relationships of these rheological variables to cardiovascular events were at least as strong as those of conventional risk factors (smoking habit, diastolic blood pressure, and low-density lipoprotein cholesterol). After adjustment for these conventional risk factors, the associations of blood viscosity and haematocrit remained significant for stroke, but not for total events; whereas the associations of plasma viscosity and fibrinogen remained significant for total events and for stroke. These findings suggest that increased blood viscosity may be one plausible biological mechanism through which increases in haematocrit and fibrinogen may promote ischaemic heart disease and stroke. Randomized controlled trials of viscosity reduction in the prevention of cardiovascular events (e.g. by lowering high levels of haematocrit or plasma fibrinogen) are suggested. |
Author | Rumley, A. Price, J. F. Lowe, G. D. O. Lee, A. J. Fowkes, F. G. R. |
Author_xml | – sequence: 1 givenname: G. D. O. surname: Lowe fullname: Lowe, G. D. O. – sequence: 2 givenname: A. J. surname: Lee fullname: Lee, A. J. – sequence: 3 givenname: A. surname: Rumley fullname: Rumley, A. – sequence: 4 givenname: J. F. surname: Price fullname: Price, J. F. – sequence: 5 givenname: F. G. R. surname: Fowkes fullname: Fowkes, F. G. R. |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2543511$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/9012704$$D View this record in MEDLINE/PubMed |
BookMark | eNqVkc1O3DAUha0KRAfoI1Syqopdgm9i52cWFTOIliIQC-jacmyn4yETg-0M5O1JNNEsWLUryzrfOfa59xgdtLbVCH0DEgOh2fk6hjRjUQIUYijLPC5YmtAC4rdPaLaXDtCMEJJHg6X4jI69XxMCKWFwhI5KAklO6AzdLRtrFd4aL603oceiVdgZ_4RtjaVwytit8LJrhMN6q9vg5zisNL5Spq0693eFFy5o1-OH0Kn-FB3WovH6y3SeoD8_rx4vr6Pb-1-_Lxe3kWSQpVEOpWSKiqpOCsaEkrSWQmpdQaIlKCUrkVFRZ7kuslImRA2fpkpRyphURJbpCTrb5T47-9JpH_hmKKCbRrTadp7nRQGMliP4dQK7aqMVf3ZmI1zPp_6D_n3Sh5KiqZ1opfF7LGE0ZQADNt9h0lnvna73BBA-roSv-Th3Ps6djyvh00r422C--GCWJohgbBucMM2_RfzYRbyaRvf_8Thf3lwPl_QdJ5KmxA |
CODEN | BJHEAL |
CitedBy_id | crossref_primary_10_1111_eci_14127 crossref_primary_10_15406_ijcam_2016_04_00107 crossref_primary_10_1021_acs_analchem_1c05208 crossref_primary_10_1108_HFF_11_2022_0629 crossref_primary_10_1161_01_CIR_97_15_1467 crossref_primary_10_1080_09513590903015486 crossref_primary_10_1097_00001721_200010000_00004 crossref_primary_10_1159_000350377 crossref_primary_10_1371_journal_pgen_1003110 crossref_primary_10_3390_jfb13040205 crossref_primary_10_1007_s00431_005_1725_9 crossref_primary_10_1590_S0004_27302006000100016 crossref_primary_10_1177_1358863X9700200207 crossref_primary_10_1016_j_clinbiochem_2012_10_015 crossref_primary_10_1177_147323001003800611 crossref_primary_10_1007_s10557_012_6402_4 crossref_primary_10_1186_s12889_024_20988_7 crossref_primary_10_1016_j_ijcard_2005_11_104 crossref_primary_10_1186_1471_2458_14_474 crossref_primary_10_1016_j_jeem_2023_102846 crossref_primary_10_17816_KMJ2021_156 crossref_primary_10_1097_00041433_199910000_00008 crossref_primary_10_4274_kvbulten_galenos_2025_85057 crossref_primary_10_1212_01_wnl_0000183057_96792_a8 crossref_primary_10_1097_MPH_0b013e31804bdb12 crossref_primary_10_1179_135100009X392458 crossref_primary_10_1007_s10067_019_04603_4 crossref_primary_10_1016_j_sna_2020_112176 crossref_primary_10_1161_HYPERTENSIONAHA_119_12780 crossref_primary_10_1016_j_jmmm_2016_11_088 crossref_primary_10_1016_j_jstrokecerebrovasdis_2016_07_031 crossref_primary_10_1111_j_1751_9004_2009_00205_x crossref_primary_10_1088_1742_6596_1073_4_042046 crossref_primary_10_23921_amp_2018v2i3_15965 crossref_primary_10_3390_ijms241914952 crossref_primary_10_3390_polym15092039 crossref_primary_10_1007_s11434_012_5165_4 crossref_primary_10_32596_ejcm_galenos_2022_2021_11_059 crossref_primary_10_1177_2047487316672004 crossref_primary_10_2217_nmt_2019_0010 crossref_primary_10_1093_ageing_afp227 crossref_primary_10_1080_10407782_2017_1293976 crossref_primary_10_1016_j_ahj_2008_08_011 crossref_primary_10_1055_s_0043_1775965 crossref_primary_10_1111_ijcp_14878 crossref_primary_10_1016_j_jstrokecerebrovasdis_2013_08_004 crossref_primary_10_1161_01_ATV_18_5_768 crossref_primary_10_3233_CH_151954 crossref_primary_10_1109_ACCESS_2019_2963355 crossref_primary_10_3390_sports7050123 crossref_primary_10_1016_j_jns_2018_11_030 crossref_primary_10_30565_medalanya_828026 crossref_primary_10_1016_j_repc_2019_04_008 crossref_primary_10_1007_s12573_011_0037_0 crossref_primary_10_1016_j_atherosclerosis_2021_09_015 crossref_primary_10_1111_j_1440_1746_2006_04266_x crossref_primary_10_1088_2631_8695_abfd47 crossref_primary_10_1115_1_4025609 crossref_primary_10_1016_j_thromres_2018_11_027 crossref_primary_10_1007_s00592_017_1004_z crossref_primary_10_1039_D4SD00188E crossref_primary_10_1161_HYPERTENSIONAHA_112_193565 crossref_primary_10_3390_ijms20174088 crossref_primary_10_1111_j_1742_1241_2004_00143_x crossref_primary_10_1115_1_4043036 crossref_primary_10_1016_j_ces_2011_12_015 crossref_primary_10_5551_jat_43968 crossref_primary_10_1055_s_0043_1775858 crossref_primary_10_3389_fphar_2020_00213 crossref_primary_10_1161_01_CIR_99_16_2192 crossref_primary_10_1016_j_metabol_2005_01_018 crossref_primary_10_1002_mrm_25015 crossref_primary_10_1016_j_bbi_2016_10_017 crossref_primary_10_1007_s10557_020_07067_w crossref_primary_10_1309_4LCN_JMPG_5U71_UWQB crossref_primary_10_3389_fmed_2023_1152747 crossref_primary_10_1016_S0140_6736_05_71810_9 crossref_primary_10_1016_j_jmmm_2015_08_094 crossref_primary_10_1371_journal_pone_0294095 crossref_primary_10_1046_j_1365_2141_1999_01158_x crossref_primary_10_1152_ajpheart_00330_2001 crossref_primary_10_1161_hc4701_099580 crossref_primary_10_1136_bmjopen_2016_011720 crossref_primary_10_1111_j_1469_8986_2007_00536_x crossref_primary_10_1210_jc_2010_0266 crossref_primary_10_1016_j_hfc_2008_03_005 crossref_primary_10_3389_fneur_2023_1320773 crossref_primary_10_1093_synbio_ysab023 crossref_primary_10_35440_hutfd_843952 crossref_primary_10_1002_ehf2_13513 crossref_primary_10_1080_19338240903392640 crossref_primary_10_1186_s12883_024_03812_y crossref_primary_10_1016_j_biopsycho_2007_09_005 crossref_primary_10_2478_jce_2020_0002 crossref_primary_10_1097_PCC_0000000000001709 crossref_primary_10_1371_journal_pone_0267747 crossref_primary_10_3390_healthcare10040665 crossref_primary_10_7759_cureus_64211 crossref_primary_10_1016_j_cca_2014_07_041 crossref_primary_10_1161_01_STR_30_4_841 crossref_primary_10_3233_CH_190701 crossref_primary_10_1080_09537104_2019_1678115 crossref_primary_10_1006_jmbi_1997_1392 crossref_primary_10_1007_s10557_018_6815_9 crossref_primary_10_2217_fnl_11_1 crossref_primary_10_1063_5_0111653 crossref_primary_10_1109_TUFFC_2005_1397353 crossref_primary_10_1111_j_1442_2042_2006_01734_x crossref_primary_10_3389_fstro_2025_1517343 crossref_primary_10_1007_s11883_000_0106_0 crossref_primary_10_1177_1076029618775511 crossref_primary_10_1002_jca_21770 crossref_primary_10_1046_j_1365_2141_2000_02026_x crossref_primary_10_3233_CH_141892 crossref_primary_10_1136_jnnp_2016_314704 crossref_primary_10_24287_1726_1708_2022_21_3_136_141 crossref_primary_10_1177_0972063416637703 crossref_primary_10_1177_03000605231169435 crossref_primary_10_1152_ajpheart_00438_2012 crossref_primary_10_1210_clinem_dgad651 crossref_primary_10_1039_C6TB01827K crossref_primary_10_3109_02699052_2013_823562 crossref_primary_10_1016_j_jstrokecerebrovasdis_2022_106687 crossref_primary_10_1016_S0015_0282_03_01173_7 crossref_primary_10_1038_aja_2011_102 crossref_primary_10_1038_s41598_021_98472_0 crossref_primary_10_1016_j_sna_2022_113456 crossref_primary_10_1038_s41598_021_00263_0 crossref_primary_10_1177_1753944716642676 crossref_primary_10_3390_ani13233694 crossref_primary_10_1038_s41598_019_42594_z crossref_primary_10_1016_j_sna_2023_114497 crossref_primary_10_1016_S1889_1837_03_71352_X crossref_primary_10_1007_s10557_010_6239_7 crossref_primary_10_1111_j_1525_1594_2010_01078_x crossref_primary_10_1002_uog_14782 crossref_primary_10_3390_app131910684 crossref_primary_10_1364_BOE_10_003974 crossref_primary_10_1089_acm_2011_0820 crossref_primary_10_1016_S0021_9150_01_00656_6 crossref_primary_10_1161_01_STR_0000181754_38408_4c crossref_primary_10_1002_ajh_26038 crossref_primary_10_1016_j_heliyon_2020_e04792 crossref_primary_10_1136_bmjopen_2020_046682 crossref_primary_10_3390_membranes12020217 crossref_primary_10_1021_ac2032386 crossref_primary_10_1097_00001721_200112000_00006 crossref_primary_10_1097_01_CCM_0000182827_50341_18 crossref_primary_10_1016_j_repce_2019_04_001 crossref_primary_10_1021_acs_analchem_9b00624 crossref_primary_10_3233_CH_211343 crossref_primary_10_1161_JAHA_123_034162 crossref_primary_10_2169_internalmedicine_55_5311 crossref_primary_10_1137_24M1632425 crossref_primary_10_18663_tjcl_1184730 crossref_primary_10_1016_j_jep_2009_01_017 crossref_primary_10_1111_j_1523_1755_2004_00484_x crossref_primary_10_1161_CIRCULATIONAHA_105_557132 crossref_primary_10_1111_j_1748_1716_2009_02037_x crossref_primary_10_3390_bioengineering11121298 crossref_primary_10_2217_clp_12_65 crossref_primary_10_3389_fphys_2020_616145 crossref_primary_10_1007_s10544_019_0426_5 crossref_primary_10_2217_bmm_2019_0246 crossref_primary_10_7759_cureus_41657 crossref_primary_10_1016_j_ejvs_2024_09_036 crossref_primary_10_1111_j_1365_2362_2005_01437_x crossref_primary_10_2217_bmm_2019_0483 crossref_primary_10_1289_ehp_5646 crossref_primary_10_1111_j_1469_8986_2006_00485_x crossref_primary_10_1080_10739680802229316 crossref_primary_10_2217_bmm_16_10 crossref_primary_10_1016_j_saa_2019_04_028 crossref_primary_10_1016_S0167_4943_00_00063_7 crossref_primary_10_1007_s00380_019_01486_y crossref_primary_10_1007_s00216_017_0218_9 crossref_primary_10_1016_j_envint_2018_04_047 crossref_primary_10_1021_ac9016659 crossref_primary_10_1253_circj_CJ_22_0512 crossref_primary_10_1021_acs_analchem_6b03347 crossref_primary_10_1038_s41598_018_25317_8 crossref_primary_10_1067_mhj_2002_119758 crossref_primary_10_1007_s00484_013_0641_3 crossref_primary_10_1016_j_heliyon_2024_e27954 crossref_primary_10_1136_bmjopen_2014_005067 crossref_primary_10_4103_0028_3886_284386 crossref_primary_10_1152_japplphysiol_00024_2022 crossref_primary_10_1080_09537100600800529 crossref_primary_10_1177_0267659112463487 crossref_primary_10_1016_j_atherosclerosis_2015_07_014 crossref_primary_10_1159_000494735 crossref_primary_10_1016_j_snb_2016_04_126 crossref_primary_10_2139_ssrn_4090386 crossref_primary_10_1002_jps_24302 crossref_primary_10_1186_s40560_023_00665_4 crossref_primary_10_1115_1_1427042 crossref_primary_10_1007_s10072_021_05666_5 crossref_primary_10_1038_s41598_017_01636_0 crossref_primary_10_1007_s12020_014_0451_3 crossref_primary_10_3389_fnut_2025_1530908 crossref_primary_10_1007_s11332_018_0486_6 crossref_primary_10_1016_j_dsx_2012_05_009 crossref_primary_10_3390_biomedicines13010015 crossref_primary_10_1159_000083845 crossref_primary_10_4236_ojpm_2015_54019 crossref_primary_10_1111_iwj_13949 crossref_primary_10_1016_j_jbiomech_2012_01_020 crossref_primary_10_1016_S0049_3848_00_00230_9 crossref_primary_10_1097_00001721_200310000_00001 crossref_primary_10_1111_j_1600_051X_2011_01710_x crossref_primary_10_1038_s41467_022_28823_6 crossref_primary_10_1111_j_1542_4758_2012_00671_x crossref_primary_10_1161_hc3501_094232 crossref_primary_10_1016_j_thromres_2024_03_032 crossref_primary_10_1016_j_envpol_2022_119071 crossref_primary_10_20915_2077_1177_2024_20_1_17_30 crossref_primary_10_1007_s00281_011_0290_8 crossref_primary_10_1081_CEH_120005376 crossref_primary_10_1093_qjmed_hch130 crossref_primary_10_1161_CIRCULATIONAHA_105_541433 crossref_primary_10_1097_MD_0000000000005041 crossref_primary_10_2217_bmm_2020_0249 crossref_primary_10_1097_MJT_0000000000000183 crossref_primary_10_1007_s12573_012_0048_5 crossref_primary_10_3390_jcm12247623 crossref_primary_10_1046_j_1423_0410_1998_7510078_x crossref_primary_10_1016_j_scitotenv_2023_164469 crossref_primary_10_5853_jos_2021_02831 crossref_primary_10_1182_blood_2016_10_746479 crossref_primary_10_1111_j_1538_7836_2007_02481_x crossref_primary_10_1016_S0021_9150_99_00114_8 crossref_primary_10_1161_HYPERTENSIONAHA_112_191510 crossref_primary_10_1142_S0217979205030190 crossref_primary_10_1016_j_amjcard_2006_01_034 crossref_primary_10_47582_jompac_1424294 crossref_primary_10_3389_fendo_2022_1059473 crossref_primary_10_1088_0960_1317_19_11_115005 crossref_primary_10_1161_01_ATV_17_11_3321 crossref_primary_10_3233_BIR_200240 crossref_primary_10_1016_j_biopsycho_2005_12_004 crossref_primary_10_1103_PhysRevLett_128_094502 crossref_primary_10_1046_j_1526_0968_2002_00366_x crossref_primary_10_1016_j_bbi_2011_09_009 crossref_primary_10_1177_1753944714553226 crossref_primary_10_1007_s10654_015_0060_3 crossref_primary_10_1016_S1078_5884_97_80290_0 crossref_primary_10_3341_jkos_2015_56_5_753 crossref_primary_10_3390_jcm12010353 crossref_primary_10_3390_pr7060372 crossref_primary_10_1016_j_bpj_2021_05_013 crossref_primary_10_1016_j_thromres_2006_11_009 crossref_primary_10_1016_j_snb_2020_128240 crossref_primary_10_1097_01_hco_0000167722_22453_47 crossref_primary_10_1186_1743_8977_2_2 crossref_primary_10_1007_s00394_016_1170_8 crossref_primary_10_3389_fcell_2021_651776 crossref_primary_10_1053_j_jvca_2019_04_005 crossref_primary_10_1097_JOM_0b013e3182619018 crossref_primary_10_1186_s40981_018_0185_y crossref_primary_10_3390_ijerph9072312 crossref_primary_10_1007_s11239_023_02881_z crossref_primary_10_1185_030079903125002289 crossref_primary_10_1111_j_1742_1241_2003_tb10437_x crossref_primary_10_3390_s22103804 crossref_primary_10_1080_08037050310060508 crossref_primary_10_1016_j_jmbbm_2012_11_008 crossref_primary_10_1016_j_nantod_2022_101517 crossref_primary_10_1016_S0021_9150_98_00144_0 crossref_primary_10_1103_PhysRevE_84_011905 crossref_primary_10_1016_j_thromres_2022_02_016 crossref_primary_10_1373_clinchem_2013_204701 crossref_primary_10_1016_S0895_7061_00_00267_3 crossref_primary_10_1080_00984100290071676 crossref_primary_10_1063_5_0060908 crossref_primary_10_3233_CH_15120 crossref_primary_10_1155_2016_1961327 crossref_primary_10_1097_00005768_200002000_00014 crossref_primary_10_1177_0267659113505637 crossref_primary_10_1007_s40279_017_0715_1 crossref_primary_10_1016_j_diabres_2019_107918 crossref_primary_10_1046_j_1526_0968_2001_00368_x crossref_primary_10_1016_j_thromres_2010_04_006 crossref_primary_10_1186_s12882_017_0808_y crossref_primary_10_1097_00001573_199903000_00016 crossref_primary_10_1016_j_clinbiochem_2014_01_021 crossref_primary_10_3390_life13102043 crossref_primary_10_1016_S0021_9150_98_00090_2 crossref_primary_10_1046_j_1365_2141_2003_04475_x crossref_primary_10_1182_blood_2017_03_745349 crossref_primary_10_1080_20565623_2025_2467607 crossref_primary_10_1063_5_0136309 crossref_primary_10_1177_0267659116661052 crossref_primary_10_1186_s12884_024_07096_5 crossref_primary_10_1016_S0268_9499_99_90084_X crossref_primary_10_1039_C8NR04398A crossref_primary_10_1080_03091902_2016_1181216 crossref_primary_10_1039_D0LC00248H crossref_primary_10_1002_phy2_261 crossref_primary_10_1111_bju_12037 crossref_primary_10_1016_j_mvr_2014_06_013 crossref_primary_10_1016_j_wneu_2022_11_102 crossref_primary_10_1097_MCA_0000000000000661 crossref_primary_10_1378_chest_06_2179 crossref_primary_10_1063_1_3116641 crossref_primary_10_1016_j_atherosclerosis_2011_08_026 crossref_primary_10_3109_02713683_2014_990638 crossref_primary_10_1037_0022_006X_70_3_548 crossref_primary_10_1097_MBC_0000000000001081 crossref_primary_10_1186_s12933_024_02513_7 crossref_primary_10_1177_1753944717745507 crossref_primary_10_1016_j_jtherbio_2020_102622 crossref_primary_10_1016_j_jvs_2014_01_069 crossref_primary_10_1177_147323000903700204 crossref_primary_10_1055_s_0040_1720968 crossref_primary_10_1016_j_clinbiochem_2014_11_006 crossref_primary_10_1111_andr_13283 crossref_primary_10_3233_CH_189413 crossref_primary_10_1017_S0007114510001923 crossref_primary_10_1046_j_1365_2796_2002_01014_x crossref_primary_10_1016_j_phymed_2008_10_014 crossref_primary_10_1155_2018_5952021 crossref_primary_10_3390_ijms24043784 crossref_primary_10_47429_lmo_2021_11_3_162 crossref_primary_10_1016_j_thromres_2004_08_028 crossref_primary_10_1002_art_22766 crossref_primary_10_1177_1076029609339745 crossref_primary_10_3233_CH_151960 crossref_primary_10_1113_EP088315 crossref_primary_10_1002_ajh_23713 crossref_primary_10_1016_j_thromres_2016_09_019 crossref_primary_10_1159_000431362 crossref_primary_10_1046_j_1365_2141_1998_00626_x crossref_primary_10_1097_01_mca_0000071769_74379_49 crossref_primary_10_3109_09513590_2011_569783 crossref_primary_10_1046_j_1365_2796_1999_00410_x crossref_primary_10_3346_jkms_2016_31_12_1943 crossref_primary_10_15406_mojce_2018_04_00115 crossref_primary_10_1007_s42452_019_0737_4 crossref_primary_10_1016_j_wneu_2016_04_110 crossref_primary_10_1126_scirobotics_aav4317 crossref_primary_10_1136_oem_57_1_53 crossref_primary_10_1080_15287390590930171 crossref_primary_10_3233_CH_151974 crossref_primary_10_2174_1871529X21666211214154545 crossref_primary_10_1016_j_brainres_2018_08_023 |
ContentType | Journal Article |
Copyright | 1997 INIST-CNRS |
Copyright_xml | – notice: 1997 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1046/j.1365-2141.1997.8532481.x |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1365-2141 |
EndPage | 173 |
ExternalDocumentID | 9012704 2543511 10_1046_j_1365_2141_1997_8532481_x BJH853 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | United Kingdom Scotland Great Britain Europe |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1KJ 1OB 1OC 23N 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6J9 6P2 702 7PT 8-0 8-1 8-3 8-4 8-5 8F7 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAKAS AAMMB AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAYEP AAZKR ABCQN ABCUV ABEML ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN AEFGJ AEGXH AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFEBI AFFNX AFFPM AFGKR AFRAH AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHEFC AI. AIACR AIAGR AIDQK AIDYY AIQQE AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EGARE EJD EMOBN EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IH2 IHE IX1 J0M J5H K48 KBYEO L7B LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N4W N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 V8K V9Y VH1 W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WVDHM WXI WXSBR X7M XG1 YFH YOC YUY ZGI ZXP ZZTAW ~IA ~WT AAHHS AAYXX ACCFJ ADZOD AEEZP AEQDE AIWBW AJBDE CITATION IQODW 24P AEUQT AFPWT CGR CUY CVF ECM EIF ESX NPM WRC WUP YIN 7X8 |
ID | FETCH-LOGICAL-c5163-719c5d4abf2855adc4fcaceeb12ec1ddcba64af67e869c20d0514dd4455cd0c93 |
IEDL.DBID | DR2 |
ISSN | 0007-1048 |
IngestDate | Fri Jul 11 03:00:02 EDT 2025 Wed Feb 19 02:35:50 EST 2025 Mon Jul 21 09:13:58 EDT 2025 Thu Apr 24 22:59:38 EDT 2025 Tue Jul 01 00:54:26 EDT 2025 Sun Sep 21 06:13:52 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Human Viscosity Nervous system diseases Stroke Rheology Cardiovascular disease Coronary heart disease Epidemiology Blood Cerebral disorder Vascular disease Central nervous system disease Risk factor Fibrinogen Hematocrite Coagulation factor Cerebrovascular disease Public health |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5163-719c5d4abf2855adc4fcaceeb12ec1ddcba64af67e869c20d0514dd4455cd0c93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2141.1997.8532481.x |
PMID | 9012704 |
PQID | 78815499 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_78815499 pubmed_primary_9012704 pascalfrancis_primary_2543511 crossref_primary_10_1046_j_1365_2141_1997_8532481_x crossref_citationtrail_10_1046_j_1365_2141_1997_8532481_x wiley_primary_10_1046_j_1365_2141_1997_8532481_x_BJH853 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 1900 |
PublicationDate | January 1997 1997-01-00 1997 1997-Jan 19970101 |
PublicationDateYYYYMMDD | 1997-01-01 |
PublicationDate_xml | – month: 01 year: 1997 text: January 1997 |
PublicationDecade | 1990 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: Oxford – name: England |
PublicationTitle | British journal of haematology |
PublicationTitleAlternate | Br J Haematol |
PublicationYear | 1997 |
Publisher | Blackwell Science Ltd Blackwell |
Publisher_xml | – name: Blackwell Science Ltd – name: Blackwell |
SSID | ssj0013051 |
Score | 2.0840724 |
Snippet | We examined the relationships of whole blood viscosity and its major determinants to incident cardiovascular events (ischaemic heart disease and stroke) in a... |
SourceID | proquest pubmed pascalfrancis crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 168 |
SubjectTerms | Aged Biological and medical sciences Blood Viscosity Cardiology. Vascular system Cerebrovascular Disorders - blood Cerebrovascular Disorders - etiology Coronary heart disease Female fibrinogen Fibrinogen - analysis Follow-Up Studies haematocrit Heart Humans ischaemic heart disease Male Medical sciences Middle Aged Myocardial Ischemia - blood Myocardial Ischemia - etiology Risk Factors stroke |
Title | Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1046%2Fj.1365-2141.1997.8532481.x https://www.ncbi.nlm.nih.gov/pubmed/9012704 https://www.proquest.com/docview/78815499 |
Volume | 96 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9tAEB5CDqUQmj4SqrRp99CrjLSe1aO35oUJuIfQQG7LPrQQ2sohtkvdX9-ZleTgJoe09CYhRkijWc0nzTffAHwo0MjK5TJFgtMplvSBYotAW05SPixMESz3Dk8_F5NLPL9SV317NPfCdPoQ6x9uvDLi-5oXuLHdFJIsqtsODK0cc265K0eUeCRW-YgRJR1iIf2TC3lXUshUPz6vpHcPVoMCKd6Rve6faiNb7dyYOTkudBMvHoKkmwg3pqizXfg-3FzHTPk6Wi7syP36Q_fxf939c3jWY1nxqQu-F7DVtC_hybSv1r-C6RGz4sWP67ljathKmNYL5rKLWRBugwgropDU_KMgPCpOKZ_G6g-furldCSY7rvbg8uz0y_Ek7cc3pE4RykvLvHbKo7FBVkoZ7zA4QznZ5rJxuffOGoqUUJRNVdROZp6l2L1HVMr5zNXjfdhuZ23zGoSsK4JSYwyELnBsVC29zywqGwiQVdIlUA-PSbte25xHbHzTscaO3I_G_tLsL83-0r2_9M8Exmvbm07h41FWhxvRsDZlcQECsQm8H6JD04LlKoxpm9lyrlm_nz_KE9jvgmZtWkcaACZQxif_F1ejj84ntHPwz5Zv4Gmny8v_lt7C9uJ22RwS2lrYd3EV_QaQhxgV |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5VRQIkxLsiQKkPXLNsvOM8uFHUailND6iVerP8iKUKlK26u1WXX8-Mk2y1wAEQt-QwUTyZ8XzxfP4M8DZHI0uXyRQJTqdY0A-KzQNdOUn1MDd5sLx3uD7Jp2d4dK7Ot6Ae9sJ0-hDrBTfOjDhfc4LzgvS7vi3ZZXmkaGWY8Z67YkSVR2KZjQhS3okNO8ZIX-RtU2Gs-gP0Cpp9sBw0SPGW7vXrszbq1YNLMyfXhe7Mi9-B0k2MG4vU4SNoh-F13JSvo-XCjtz3n5Qf_9v4H8PDHs6KD138PYGtpn0Kd-u-Yf8M6n0mxovri7ljdthKmNYLprOLWRBugwsropbU_L0gSCoOqKTGBhA_urlaCeY7rp7D2eHB6cdp2p_gkDpFQC8tssopj8YGWSplvMPgDJVlm8nGZd47ayhYQl40ZV45Ofasxu49olLOj1012YHtdtY2L0DIqiQ0NcFAAAMnRlXS-7FFZQNhslK6BKrhO2nXy5vzKRvfdGyzI29JY39p9pdmf-neX_omgcna9rIT-fgjq92NcFibsr4A4dgE9obw0JSz3IgxbTNbzjVL-PN_eQI7XdSsTavIBMAEivjp_-Jt9P7RlG5e_rPlHtybntbH-vjTyedXcL-T6eWlptewvbhaNrsEvhb2TUypHyd3HDM |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEB6hIlVIqOVV4T7oHrg6xJtZP7i10CgUUiFEpd5W-_BKFeBETYIIv56ZtZMqwAEQN_swlj074_ns-eZbgOc5Glm6TKZIcDrFgj5QbB7oyEmqh7nJg-XZ4fFFPrrE8yt11Y1H8yxMqw-x_uHGmRHf15zgUx9edF3JNskjQyvDjEfuih4VHoll1iNEeRdzqpsMkT7I255CX3X75xX08sFyJUGKt2yvX6-1Ua7uT82MPBfaLS9-h0k3IW6sUcNd-LJ6upaa8qm3mNue-_6T8OP_evwHsNOBWXHSRt9DuFM3j2B73LXrH8P4lGnx4uv1zDE3bClM4wWT2cUkCLfBhBVRSWr2UhAgFWdUUGP7hy9d3ywFsx2XT-ByePbx1Sjt9m9InSKYlxZZ5ZRHY4MslTLeYXCGirLNZO0y7501FCohL-oyr5zse9Zi9x5RKef7rhrswVYzaeqnIGRVEpYaYCB4gQOjKul936KygRBZKV0C1WqZtOvEzXmPjc86NtmRB9LYX5r9pdlfuvOX_pbAYG07bSU-_sjqaCMa1qasLkAoNoHjVXRoylhuw5imnixmmgX8-as8gb02aNamVeQBYAJFXPm_uBt9ej6ik_1_tjyG7fevh_rdm4u3B3Cv1ejl_0yHsDW_WdRHhLzm9llMqB-mahri |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Blood+viscosity+and+risk+of+cardiovascular+events+%3A+The+Edinburgh+Artery+Study&rft.jtitle=British+journal+of+haematology&rft.au=LOWE%2C+G.+D.+O&rft.au=LEE%2C+A.+J&rft.au=RUMLEY%2C+A&rft.au=PRICE%2C+J.+F&rft.date=1997&rft.pub=Blackwell&rft.issn=0007-1048&rft.volume=96&rft.issue=1&rft.spage=168&rft.epage=173&rft_id=info:doi/10.1046%2Fj.1365-2141.1997.8532481.x&rft.externalDBID=n%2Fa&rft.externalDocID=2543511 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1048&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1048&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1048&client=summon |